Singh, Aman
von Vogelsang, Ann-Christin
Tatter, Charles
El-Hajj, Victor Gabriel
Fletcher-Sandersjöö, Alexander
Cewe, Paulina
Nilsson, Gunnar
Blixt, Simon
Gerdhem, Paul
Edström, Erik
Elmi-Terander, Adrian http://orcid.org/0000-0002-3776-6136
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 13 November 2023
Accepted: 26 December 2023
First Online: 20 February 2024
Declarations
:
: Swespine uses the opt-out method, meaning that patient consent is not needed to be part of the quality registry, but answering the questionnaires is voluntary. The Regional and National Ethical Review Boards authorized the study and the use of the data collection (Dnr: 2016/1708–31/4, 2020–00193, 2021–04773, 2021–00759, 2022–00187).
: The authors declare no competing interests.
: The funding sources had no role in the study design, analysis, or interpretation of the data; in the manuscript writing; or in the decision to submit the paper for publication. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.